DarioHealth Analyst Ratings
DarioHealth Analyst Ratings
While ratings are subjective and will change, the latest DarioHealth (DRIO) rating was a maintained with a price target of $5.45 to $4.10. The current price DarioHealth (DRIO) is trading at is $3.15, which is out of the analyst's predicted range.| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/11/2023 | 30.16% | Alliance Global Partners | $5.45 → $4.1 | Maintains | Buy |
| 07/25/2023 | 90.48% | Stifel | $9 → $6 | Maintains | Buy |
| 05/12/2023 | 153.97% | Craig-Hallum | $14 → $8 | Maintains | Buy |
| 11/16/2022 | 138.1% | Alliance Global Partners | $9.15 → $7.5 | Maintains | Buy |
| 08/18/2022 | 376.19% | Aegis Capital | $20 → $15 | Maintains | Buy |
| 08/16/2022 | 344.44% | Cowen & Co. | $18 → $14 | Maintains | Outperform |
| 05/16/2022 | 534.92% | Aegis Capital | $23 → $20 | Maintains | Buy |
| 05/16/2022 | 471.43% | Cowen & Co. | $14 → $18 | Maintains | Outperform |
| 05/13/2022 | — | Alliance Global Partners | Upgrades | Neutral → Buy | |
| 01/26/2022 | 693.65% | Aegis Capital | $28 → $25 | Maintains | Buy |
| 08/19/2021 | 788.89% | Aegis Capital | $35 → $28 | Maintains | Buy |
| 04/22/2021 | 884.13% | Cowen & Co. | → $31 | Initiates Coverage On | → Outperform |
| 03/23/2021 | 852.38% | Stifel | → $30 | Initiates Coverage On | → Buy |
| 02/08/2021 | 1011.11% | Aegis Capital | $25 → $35 | Maintains | Buy |
| 08/17/2020 | 693.65% | Aegis Capital | → $25 | Initiates Coverage On | → Buy |
| 06/22/2020 | 217.46% | ThinkEquity | → $10 | Initiates Coverage On | → Buy |
| 05/13/2020 | 153.97% | Craig-Hallum | $7 → $8 | Maintains | Buy |
| 06/06/2019 | -52.38% | Craig-Hallum | → $1.5 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
|---|---|---|---|---|---|
| 2023年08月11日 | 30.16% | 聯盟全球合作夥伴 | $5.45→$4.1 | 維護 | 買 |
| 07/25/2023 | 90.48% | Stifel | $9→$6 | 維護 | 買 |
| 2023年05月12日 | 153.97% | 克雷格-哈勒姆 | $14→$8 | 維護 | 買 |
| 2022年11月16日 | 138.1% | 聯盟全球合作夥伴 | $9.15→$7.5 | 維護 | 買 |
| 2022/08/18 | 376.19% | 宙斯盾資本 | $20→$15 | 維護 | 買 |
| 08/16/2022 | 344.44% | 考恩公司 | $18→$14 | 維護 | 跑贏大盤 |
| 05/16/2022 | 534.92% | 宙斯盾資本 | $23→$20 | 維護 | 買 |
| 05/16/2022 | 471.43% | 考恩公司 | $14→$18 | 維護 | 跑贏大盤 |
| 2022年05月13日 | - | 聯盟全球合作夥伴 | 升級 | 中性→購買 | |
| 2022年01月26日 | 693.65% | 宙斯盾資本 | $28→$25 | 維護 | 買 |
| 2021/08/19 | 788.89% | 宙斯盾資本 | $35→$28 | 維護 | 買 |
| 04/22/2021 | 884.13% | 考恩公司 | →$31 | 開始承保 | →跑贏大盤 |
| 03/23/2021 | 852.38% | Stifel | →$30 | 開始承保 | →購買 |
| 02/08/2021 | 1011.11% | 宙斯盾資本 | $25→$35 | 維護 | 買 |
| 2020/08/17 | 693.65% | 宙斯盾資本 | →$25 | 開始承保 | →購買 |
| 06/22/2020 | 217.46% | ThinkEquity | →$10 | 開始承保 | →購買 |
| 2020/05/13 | 153.97% | 克雷格-哈勒姆 | $7→$8 | 維護 | 買 |
| 2019年06月06日 | -52.38% | 克雷格-哈勒姆 | →$1.5 | 開始承保 | →購買 |
What is the target price for DarioHealth (DRIO)?
DarioHealth的目標價是多少？
The latest price target for DarioHealth (NASDAQ: DRIO) was reported by Alliance Global Partners on August 11, 2023. The analyst firm set a price target for $4.10 expecting DRIO to rise to within 12 months (a possible 30.16% upside). 6 analyst firms have reported ratings in the last year.
聯盟全球合作夥伴於2023年8月11日報道了DarioHealth(納斯達克：DIO)的最新目標價。這家分析公司將目標價定為4.10美元，預計Drio將在12個月內上漲(可能上漲30.16%)。6家分析公司在過去一年公佈了評級。
What is the most recent analyst rating for DarioHealth (DRIO)?
分析師對DarioHealth的最新評級是多少？
The latest analyst rating for DarioHealth (NASDAQ: DRIO) was provided by Alliance Global Partners, and DarioHealth maintained their buy rating.
達裡奧健康(納斯達克代碼：DIO)的最新分析師評級由聯盟全球合作夥伴提供，達裡奧健康維持買入評級。
When is the next analyst rating going to be posted or updated for DarioHealth (DRIO)?
DarioHealth的下一次分析師評級將於何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of DarioHealth, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for DarioHealth was filed on August 11, 2023 so you should expect the next rating to be made available sometime around August 11, 2024.
分析師在進行了廣泛的研究後得出了股票評級，其中包括查閱公共財務報表，與DarioHealth的高管和客戶交談，以及聽取收益電話會議。大多數分析師每三個月就會這樣做一次，所以你每年應該會得到每家公司每家公司的4個評級。DarioHealth的上一次評級是在2023年8月11日提交的，所以你應該預計下一次評級將在2024年8月11日左右提供。
Is the Analyst Rating DarioHealth (DRIO) correct?
分析師對DarioHealth的評級正確嗎？
While ratings are subjective and will change, the latest DarioHealth (DRIO) rating was a maintained with a price target of $5.45 to $4.10. The current price DarioHealth (DRIO) is trading at is $3.15, which is out of the analyst's predicted range.
雖然評級是主觀的，並將發生變化，但最新的DarioHealth(Drio)評級保持不變，目標價在5.45美元至4.10美元之間。DarioHealth目前的交易價格為3.15美元，超出了分析師的預測區間。